NPI Details
DR. Michael T Patton, D.O. is an internal medicine in Santa Rosa Beach, FL with 26 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Michael T Patton, D.O. NPI is 1245200633. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
5551 US HIGHWAY 98
SANTA ROSA BEACH, FL
ZIP 32459
Phone: (850) 420-5420
Fax: (850) 244-8011
The NPI 1245200633 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
- Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Automated urinalysis test (HCPCS:81003)
- X-ray of chest, 2 views (HCPCS:71046)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
- Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
- New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
- Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
- Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
- Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
- Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring (HCPCS:M0245)
- Injection, bamlanivimab and etesevimab, 2100 mg (HCPCS:Q0245)
- Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
- Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
- Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Hemoglobin a1c level (HCPCS:83036)
- Injection, sotrovimab, 500 mg (HCPCS:Q0247)
- Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
- Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
- Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
The enumeration date for this NPI number is 1/26/2006 and was last updated on 2/4/2022.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | DO751 | ALABAMA | No |
| 2 | 207R00000X | Internal Medicine | | OS8656 | FLORIDA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 107345200 | MEDICAID | FLORIDA | |
| 2 | 51002860 | OTHER | ALABAMA | BLUE CROSS OF AL |
